Characterisation of the novel HLA‐B*38:01:01:18 allele by next‐generation sequencing
HLA · 2024
DOI: 10.1111/tan.15573 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Diamanto Kouniaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Histocompatibility Department, Evangelismos General Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Alleles, High-Throughput Nucleotide Sequencing, HLA-B Antigens, 5' Untranslated Regions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*38:01:01:18 differs from the HLA‐B*38:01:01:01 allele by one nucleotide substitution in the 5′UTR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology and Histocompatibility Department, Evangelismos General Hospital, Athens, Greece.
ORCID-Profile: Diamanto Kouniaki, Alexandra Tsirogianni
Zitieren
APA
Kouniaki, D., Kitsiou, V., & Tsirogianni, A. (2024). Characterisation of the novel HLA‐B*38:01:01:18 allele by next‐generation sequencing. HLA. https://doi.org/10.1111/tan.15573
Vancouver
Kouniaki D, Kitsiou V, Tsirogianni A. Characterisation of the novel HLA‐B*38:01:01:18 allele by next‐generation sequencing. HLA. 2024. doi:10.1111/tan.15573
BibTeX
@article{Kouniaki2024,
author = {Kouniaki, Diamanto and Kitsiou, Vasiliki and Tsirogianni, Alexandra},
title = {Characterisation of the novel HLA‐B*38:01:01:18 allele by next‐generation sequencing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15573}
}
EUVIMED